glutathione for lung cancer Utilizing glutathione-triggered nanoparticles to enhance chemotherapy of by reprograming the tumor microenvironment LCS3 is a Glutathione Disulfide
Description
Bortezomib, a proteasome inhibitor (PI) which depletes non-malignant plasma cells, was proposed to reduce anti-donor HLA antibody
Pigment cell research, 14(3), 155-160
CPT 96372 is used for therapeutic, prophylactic, or diagnostic injections intramuscularly or subcutaneously
A growing body of evidence supports switching to a different GLP-1 compound or combining agents
K., Sibbritt, D., Dawson, A
